For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Delcath Systems, Inc.

USPTO Granted Patents = 19

EPO Patents = 9

Trademarks = 9

Forward Citations = 660

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

William M Appling (12 out of 68 patents)

Daniel Stephen Johnston (9 out of 11 patents)

Jacques Chammas (7 out of 18 patents)

4. Samantha J Barton (7 out of 7 patents)

5. Matthew G Barton (5 out of 5 patents)

6. Stephen N Engelhard (4 out of 4 patents)

7. Morton G Glickman (4 out of 6 patents)

8. Eamonn P Hobbs (2 out of 24 patents)

9. William L Bodden (1 out of 2 patents)

19 patents: Sort by Forward Citations

1. 12364797 - Apparatus for removing chemotherapy compounds from blood (2025-07-22),

2. 11867686 - Method of selecting chemotherapeutic agents for an isolated organ or regional therapy (2024-01-09),

3. 11833286 - Filter and frame apparatus and method of use (2023-12-05),

4. 11633528 - Apparatus for removing chemotherapy compounds from blood (2023-04-25),

5. 11241522 - Apparatus for removing chemotherapy compounds from blood (2022-02-08),

6. 11083831 - Filter and frame apparatus and method of use (2021-08-10),

7. 10569004 - Apparatus for removing chemotherapy compounds from blood (2020-02-25),

8. 10369264 - Apparatus for removing chemotherapy compounds from blood (2019-08-06),

9. 10195334 - Filter and frame apparatus and method of use (2019-02-05),

10. 10098997 - Apparatus for removing chemotherapy compounds from blood (2018-10-16),

11. 9707331 - Apparatus for removing chemotherapy compounds from blood (2017-07-18),

12. 9541544 - Method of selecting chemotherapeutic agents for an isolated organ or regional therapy (2017-01-10),

13. 9314561 - Filter and frame apparatus and method of use (2016-04-19),

14. D708749 - Dual filter (2014-07-08),

15. 5919163 - Catheter with slidable balloon (1999-07-06),

Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. They develop a unique system for the delivery of high-dose chemotherapy directly to the liver, known as the Delcath Hepatic Delivery System. This targeted therapy aims to improve treatment outcomes for patients with liver metastases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

19 Patents

#369 in New York, NY

#927 in New York

#16,592 in US

#31,670 in the World

New York, NY, United States of America

Delcath Systems, Inc.

Forward Citations = 660

9 inventors:

William M Appling (12 out of 68 patents)

Daniel Stephen Johnston (9 out of 11 patents)

Jacques Chammas (7 out of 18 patents)

4. Samantha J Barton (7 out of 7 patents)

5. Matthew G Barton (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…